Q: Can you describe some of the initial challenges you faced in understanding how the CRISPR system works?...
Q: Can you share some of the latest discoveries in new drugs and diagnostics that scientists at the Helen Diller Family Comprehensive Cancer Center are working on?...
Q: What challenges are there when it comes to defining the commercialization strategy for when marrying a drug with a diagnostics?...
Anil Sethi: “It’s fine to talk about cutting edge immunotherapy, biomarkers for early detection of disease, and the implications of ‘big data’. But there are dirty little secrets surrounding big-data in healthcare…. we’ve got to think much smaller. Small data; N-of-1; The individual. Collected patient...
The startup world is changing! [Link] Startups in “hard sciences” like biology or chemistry are now getting the attention they deserve from big investors and Fortune 500 companies....
Q: What impact will a pay-for-performance model have on healthcare, the patient and physician, the pharmaceutical industry, or the health insurance provider?...
We had a chance to sit down with Dr. Simon Kos, CMO, Microsoft who will be speaking at our upcoming PMWC 2018 Silicon Valley conference this coming January....
Each plays a critical role in shaping the human healthcare system, moving it from a general population approach toward a personalized and patient-centered care model...
Artificial Intelligence and machine learning are on everyones' minds these days, and they are poised to become game changers in many areas, including the healthcare sector...
We had a chance to sit down with Dr. Slava Akmaev - who will be speaking at our upcoming PMWC 2018 Silicon Valley conference this coming January - to discuss his vision of "why data-driven research is important, and how machine learning and AI will advance...
